Foresite Capital Management IV, LLC Diversified Active

Name: Foresite Capital Management IV, LLC Q2 2019 13F Filing | 13F Explorer
Creator: Foresite Capital Management IV, LLC
Published: 2019-08-13

Location: West Hollywood, CA

CIK: 0001704132 · Show all filings

Period: Q2 2019 (← Previous) (Next →)

Filing Date: Aug 13, 2019

Total Value: $354M (100.0% shares, 0.0% debt)

Holdings (22)

— Turning Point Therapeutics, Inc. 21.1%

Value $74.49M Shares 1,830,265 Est. Cost $40.70 Unrealized —

INSM Insmed Incorporated 11.3%

Value $39.97M Shares 1,561,185 Est. Cost $26.85 Unrealized +3.8%

ASND Ascendis Pharma A/S 8.0%

Value $28.26M Shares 245,424 Est. Cost $40.06 Unrealized —

ALEC Alector, Inc. 6.1%

Value $21.73M Shares 1,143,462 Est. Cost $18.92 Unrealized +7.3%

CYTK Cytokinetics Incorporated 6.0%

Value $21.36M Shares 1,898,970 Est. Cost $7.56 Unrealized +27.5%

— Biohaven Pharmaceutical Holding Company Ltd. 5.3%

Value $18.82M Shares 429,690 Est. Cost $26.07 Unrealized —

— CymaBay Therapeutics, Inc. 5.2%

Value $18.41M Shares 2,571,258 Est. Cost $8.89 Unrealized —

REPL Replimune Group, Inc. 5.1%

Value $18.01M Shares 1,228,656 Est. Cost $17.53 Unrealized -17.5%

— OptiNose, Inc. 5.0%

Value $17.86M Shares 2,522,189 Est. Cost $15.00 Unrealized —

— Aerie Pharmaceuticals, Inc. 5.0%

Value $17.73M Shares 600,000 Est. Cost $31.86 Unrealized —

VYGR Voyager Therapeutics, Inc. 4.1%

Value $14.61M Shares 536,771 Est. Cost $24.54 Unrealized —

— Myokardia, Inc. 3.6%

Value $12.91M Shares 257,452 Est. Cost $45.40 Unrealized —

RYTM Rhythm Pharmaceuticals, Inc. 2.9%

Value $10.33M Shares 469,482 Est. Cost $26.85 Unrealized -6.0%

— The Medicines Company 2.6%

Value $9.106M Shares 249,672 Est. Cost $36.47 Unrealized —

— NGM Biopharmaceuticals, Inc. 2.0%

Value $6.899M Shares 471,269 Est. Cost $14.64 Unrealized —

VCYT Veracyte, Inc. 1.6%

Value $5.702M Shares 200,000 Est. Cost $24.98 Unrealized 0.0%

— Immunomedics, Inc. 1.5%

Value $5.35M Shares 385,751 Est. Cost $17.13 Unrealized —

SIBN SI-BONE, Inc. 1.2%

Value $4.182M Shares 205,621 Est. Cost $18.92 Unrealized -9.3%

— Aerie Pharmaceuticals, Inc. 0.8%

Value $2.97M Shares 100,500 Est. Cost $31.86 Unrealized —

— Aerie Pharmaceuticals, Inc. 0.8%

Value $2.97M Shares 100,500 Est. Cost $31.86 Unrealized —

ABUS Arbutus Biopharma Corporation 0.4%

Value $1.265M Shares 608,151 Est. Cost $5.62 Unrealized -54.4%

— Kiniksa Pharmaceuticals, Ltd. 0.2%

Value $866K Shares 63,922 Est. Cost $17.35 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	Turning Point Therapeutics, Inc.	1,830,265	$74.49M	21.1%	$40.70	—	COM	90041T108
INSM	Insmed Incorporated	1,561,185	$39.97M	11.3%	$26.85	+3.8%	COM	457669307
ASND	Ascendis Pharma A/S	245,424	$28.26M	8.0%	$40.06	—	SPONSORED ADR	04351P101
ALEC	Alector, Inc.	1,143,462	$21.73M	6.1%	$18.92	+7.3%	COM	014442107
CYTK	Cytokinetics Incorporated	1,898,970	$21.36M	6.0%	$7.56	+27.5%	COM NEW	23282W605
—	Biohaven Pharmaceutical Holding Company Ltd.	429,690	$18.82M	5.3%	$26.07	—	COM	G11196105
—	CymaBay Therapeutics, Inc.	2,571,258	$18.41M	5.2%	$8.89	—	COM	23257D103
REPL	Replimune Group, Inc.	1,228,656	$18.01M	5.1%	$17.53	-17.5%	COM	76029N106
—	OptiNose, Inc.	2,522,189	$17.86M	5.0%	$15.00	—	COM	68404V100
—	Aerie Pharmaceuticals, Inc.	600,000	$17.73M	5.0%	$31.86	—	COM	00771V108
VYGR	Voyager Therapeutics, Inc.	536,771	$14.61M	4.1%	$24.54	—	COM	92915B106
—	Myokardia, Inc.	257,452	$12.91M	3.6%	$45.40	—	COM	62857M105
RYTM	Rhythm Pharmaceuticals, Inc.	469,482	$10.33M	2.9%	$26.85	-6.0%	COM	76243J105
—	The Medicines Company	249,672	$9.106M	2.6%	$36.47	—	COM	584688105
—	NGM Biopharmaceuticals, Inc.	471,269	$6.899M	2.0%	$14.64	—	COM	62921N105
VCYT	Veracyte, Inc.	200,000	$5.702M	1.6%	$24.98	0.0%	COM	92337F107
—	Immunomedics, Inc.	385,751	$5.35M	1.5%	$17.13	—	COM	452907108
SIBN	SI-BONE, Inc.	205,621	$4.182M	1.2%	$18.92	-9.3%	COM	825704109
—	Aerie Pharmaceuticals, Inc.	100,500	$2.97M	0.8%	$31.86	—	Call	00771V108
—	Aerie Pharmaceuticals, Inc.	100,500	$2.97M	0.8%	$31.86	—	Put	00771V108
ABUS	Arbutus Biopharma Corporation	608,151	$1.265M	0.4%	$5.62	-54.4%	COM	03879J100
—	Kiniksa Pharmaceuticals, Ltd.	63,922	$866K	0.2%	$17.35	—	Class A Common	G5269C101